Back to School: How biopharma can reboot drug development. Access exclusive analysis here

GenESA system data

GNSA (San Diego) published abstracts of Phase III studies showing its arbutamine heart stressor is as effective as exercise-induced stress.

Abnormal wall motion in the heart, identified by echochardiography, was detected by the system in 84

Read the full 361 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE